Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
New leaders appointed for Mölnlycke Health Care
Gothenburg, Sweden. 3 November 2026. Mölnlycke® announces the appointment of Anders Andersson as Chief Executive Officer (CEO) of Mölnlycke Health Care and Fredrik Wallefors as President of Surgical, effective 1 January 2027.
“Anders Andersson and Fredrik Wallefors both have the experience and drive needed to successfully lead our business into the future, maintaining our commitment to patients, healthcare professionals and customers,” says Karl-Henrik Sundström, Chair of the Board of Directors at Mölnlycke.
Anders Andersson is currently Executive Vice President (EVP) Wound Care at Mölnlycke and brings to the role a deep understanding of the business and customer needs. “It is an honour to take on the leadership of Mölnlycke Health Care into its next phase of innovation and profitable growth. Together with colleagues across the organisation, we will build on our strong foundations in wound care and infection prevention, while continuing to innovate and adapt new technologies to meet evolving customer needs and raise standards of healthcare worldwide,” Anders says.
Fredrik Wallefors is currently EVP OR Solutions at Mölnlycke and has strong knowledge and experience of the surgical market. “Our intention is to bring together our Operating Room Solutions and Gloves businesses, combining their strong positions in key segments with a broad range of complementary solutions. I look forward to building on these strengths as we continue our journey of profitable growth and support our customers in improving efficiency, safety and outcomes in surgical settings,” Fredrik says.
Mölnlycke has communicated its intention to separate into two stand-alone companies. Until the intended separation is completed, the businesses will continue to operate as Mölnlycke Health Care. From 1 January 2027, Anders Andersson will assume the CEO responsibilities of Mölnlycke Health Care and Fredrik Wallefors will be President of Surgical. The intention is that Fredrik Wallefors will assume the position as CEO of Mölnlycke Surgical if and when the separation and relevant consultations with employee representatives are completed. Guillaume Joucla will continue to serve as interim CEO of Mölnlycke Health Care until the end of 2026.
The intention is for Mölnlycke Health Care and Mölnlycke Surgical to become two stand-alone portfolio companies under Patricia Industries’ ownership. The separation is expected to be completed during 2027, subject to customary approvals.
Note to editors
Fredrik Wallefors’ title in Swedish as of 1 January 2027 is “Affärsområdeschef.”
For more information, please contact:
Latest news
-
Mölnlycke and AROA partner to expand access to Endoform in the US
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
-
Mölnlycke launches MyFit™ by Biogel® to bring more inclusive sizing to surgical gloves
Atlanta, Georgia. 13 October 2026. No two pairs of hands are the same, yet surgical glove sizing has changed little over time. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, is launching MyFit™ by Biogel®, a more inclusive range of surgical glove fit options designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
-
Mölnlycke launches Biogel® Radiation Protection® gloves to tackle low adoption of hand protection in radiation-guided surgical procedures
Clinicians’ hands can receive up to 1,000 times more radiation than other parts of the body during image-guided procedures1; yet, radiation-attenuating gloves are used in only 10% of applicable cases2, putting healthcare professionals at risk of the damaging effects of radiation.
-
Mölnlycke to separate its surgical solutions business into a standalone company
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
-
Mölnlycke Recognized with Cardinal Health 2026 Rising Star Award
Mölnlycke Health Care has been honored with the Cardinal Health 2026 Rising Star Award, recognizing outstanding performance as a new member of the Cardinal Health Performance Plus Program.The award was presented during Cardinal Health's National Sales Meeting, held the week of August 9th, and reflects the strength of the partnership between the two organizations across Advanced Wound Care, Patient Positioning, and Antiseptics.
-
Changes to Mölnlycke Health Care Board of Directors
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
-
Mölnlycke Health Care accelerates U.S. growth journey with three wound care product launches
Peachtree Corners, GA. July 7, 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has launched three product innovations in the U.S. since the start of 2026. Designed to expand access to advanced wound care solutions and strengthen the company’s U.S. presence, the portfolio expansion also supports long-term value creation across key market segments.
-
Mölnlycke Health Care announces Andreas Johansson as Interim Chief Financial Officer
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.
-
Filippa Stenberg joins Mölnlycke Board of Directors